Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 9,994 | 34,477 | 13,851 | 9,598 | 12,361 |
| Gross Profit | 9,994 | 34,477 | 13,851 | 9,598 | 12,361 |
| Operating Expenses | 176,610 | 150,536 | 120,250 | 76,577 | 48,485 |
| Operating Income | -166,616 | -116,059 | -106,399 | -66,979 | -36,124 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | 17,502 | 14,182 | 7,048 | 377 | 17 |
| Pre-tax Income | -149,114 | -101,877 | -99,351 | -66,602 | -36,127 |
| Income Tax | -9 | 193 | 70 | 321 | -1,819 |
| Net Income Continuous | -149,105 | -102,070 | -99,421 | -66,923 | -34,308 |
| Net Income | $-149,105 | $-102,070 | $-99,421 | $-66,923 | $-34,308 |
| EPS Basic Total Ops | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 |
| EPS Basic Continuous Ops | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 |
| EPS Diluted Total Ops | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 |
| EPS Diluted Continuous Ops | -1.65 | -1.38 | -1.64 | -2.11 | -4.01 |
| EPS Diluted Before Non-Recurring Items | -1.65 | -1.38 | -1.64 | -2.11 | N/A |
| EBITDA(a) | $-167,415 | $-116,959 | $-105,574 | $-65,943 | $-35,224 |